1 Growth Stock Down 25% in 2026 to Buy and Hold Previous dips turned out to be great buying opportunities with this stock.
Is Home Depot a Buy, Sell, or Hold in 2026? Shares have underperformed the S&P 500 index in the past five years.
The Ultimate Diversified Portfolio With Just 2 Vanguard ETFs Despite the choices that ETF investors have nowadays, you can literally get all the global stock and bond exposure you'd ever need with just a pair of Vanguard ETFs.
Dycom’s (NYSE:DY) Q4 CY2025: Strong Sales Telecommunications company Dycom (
NYSE:DY ) announced better-than-expected revenue in Q4 CY2025, with sales up 34.4% year on year to $1.46 billion. Guidance f...
Bath and Body Works (NYSE:BBWI) Reports Bullish Q4 CY2025 Personal care and home fragrance retailer Bath & Body Works (
NYSE:BBWI ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales fell...
Here's Why CDs Are More Risky Than You Think CDs feel safe. But locking your money up in 2026 carries a risk most savers don't think about.
Here's What Nobody Tells You Before You Buy a Nasdaq-100 ETF You might be surprised at how your money is allocated once you invest.
3 Monster Dividend Stocks Yielding Up to 10.7% These stocks should be able to maintain their big-time payouts.
Better Cryptocurrency to Buy Today With $3,500 and Hold for 5 Years: XRP vs. Cardano One of these coins is zeroed in on a specific target, and the other is a set of solutions looking for a problem to solve.
Here's What Actually Triggers a Bank to Freeze Your Account Banks can freeze your account without warning. Here's what usually triggers it and what to do next.
Wall Street's Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields Benzinga readers can find out which stocks are highest dividend-yielding, view analyst ratings, and follow the latest news on their favorite stocks.
Wix’s (NASDAQ:WIX) Q4 CY2025 Earnings Results: Revenue In Line With Expectations Website building platform Wix (
NASDAQ:WIX ) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 13.9% year on year to $524.3 million. Its non-G...
Why Did CANF Stock Soar 40% In Pre-Market Today? The company said its trial to study the treatment of patients with advanced pancreatic ductal adenocarcinoma met its primary endpoint.
These Analysts Slash Their Forecasts On GitLab Following Q4 Results GitLab, Inc. (
NASDAQ:GTLB ) reported strong Q4 earnings but issued weak fiscal year 2027 guidance. Analysts downgraded stock and lowered price targets.
